Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Cristina ORLOV-SLAVU"'
Autor:
Alexandra Lazar, Ana Maria Popa, Cristina Orlov-Slavu, Horia-Teodor Cotan, Cristian Ion Iaciu, Cristina Mihaela Olaru, Oliver Daniel Schreiner, Romeo Cristian Ciobanu, Cornelia Nitipir
Publikováno v:
Medicina, Vol 60, Iss 8, p 1290 (2024)
Background and Objectives: Ovarian cancer, including tubal and peritoneal cancer, is the third most common gynecological cancer and the leading cause of death from gynecological malignancies in developed countries. This study explores the prognostic
Externí odkaz:
https://doaj.org/article/563735baa057450c8430ec718d0b8915
Autor:
Bogdan Serban, Bogdan Cretu, Adrian Cursaru, Cornelia Nitipir, Cristina Orlov-Slavu, Catalin Cirstoiu
Publikováno v:
EFORT Open Reviews, Vol 8, Iss 8, Pp 606-614 (2023)
Soft tissue sarcomas (STS) represent a heterogeneous group of malignancies that are all distinguished by mesodermal differentiation, with unique clinical and pathologic characteristics. Only 1% of adult malignancies are STS, which makes them comparat
Externí odkaz:
https://doaj.org/article/638a0b86fcc843ecacf0a3c8266134e6
Autor:
Elena-Monica BOGHICI, Andreea-Ioana PAROSANU, Ion Cristian IACIU, Mihaela OLARU, Cristina-Florina PIRLOG, Cristina ORLOV-SLAVU, Ana-Maria POPA, Cornelia NITIPIR
Publikováno v:
Modern Medicine, Vol 30, Iss 2, Pp 157-160 (2023)
Breast cancer is one of the most common malignancies, with a 10-year survival rate for early non-metastatic stages of over 80%. However, recurrence or relapse may occur decades after completing therapy, and cancer survivors have also a risk of second
Externí odkaz:
https://doaj.org/article/bff78c217fd9459b87c40618a9f63405
Autor:
Iulian SLAVU, Cornelia NITIPIR, Cristina ORLOV-SLAVU, Alexandru DOGARU, Raluca TULIN, Constantin OPRESCU, Adrian TULIN
Publikováno v:
Modern Medicine, Vol 30, Iss 2, Pp 95-99 (2023)
Preoperative parathyroid evaluation through nuclear medicine and intraoperative hormone monitoring has significantly increased the success of the surgical intervention. Material and method: Our study is descriptive, the database is retrospective but
Externí odkaz:
https://doaj.org/article/7b1d7d72fa7d4c77a8a29e85d3153eae
Autor:
Cornelia Nitipir, Andreea Parosanu, Cristina Orlov-Slavu, Cătălin Piriianu, Radu Vrabie, Iulian Slavu, Valentin Calu
Publikováno v:
Journal of Mind and Medical Sciences, Vol 9, Iss 1, Pp 187-192 (2022)
Gastrointestinal metastases from cutaneous melanoma are rare and usually asymptomatic, with most patients not being clinically diagnosed throughout their lifetime. We report a case of how melanoma may metastasize insidiously in the small bowel. Unexp
Externí odkaz:
https://doaj.org/article/ac9da1d4b68e497599b60f3ed986f3a5
Autor:
Andreea PAROSANU, Ana-Maria POPA, Cristian IACIU, Mihaela OLARU, Cristina ORLOV-SLAVU, Horia COTAN, Miruna STANCIU, Radu VRABIE, Cornelia NITIPIR
Publikováno v:
Modern Medicine, Vol 29, Iss 1, Pp 93-97 (2022)
Paraneoplastic syndromes of the nervous system are rare disorders, strongly linked with lung cancer. This report aims to explore the challenges in the diagnosis and treatment of a patient with early-stage small cell lung cancer and neurological manif
Externí odkaz:
https://doaj.org/article/ec6491a43f004bd9973907a5016d827e
Autor:
Cristina Orlov-Slavu, Andreea Parosanu, Mihaela Olaru, Dragos Serban, Ioana Paunica, Cornelia Nitipir
Publikováno v:
Journal of Mind and Medical Sciences, Vol 8, Iss 2, Pp 215-220 (2021)
Personalized treatment in oncology is the most innovative method of care. The best method to establish personalized treatment is by genetic characterization of the malignant cell. Theoretically, the more detailed the characterization, the more effect
Externí odkaz:
https://doaj.org/article/2d58957d91f84e67a1c43a1468a84355
Autor:
Ioana-Miruna Stanciu, Cristina Florina Pirlog, Andrei-Wilhelm Anghel, Andreea Ioana Parosanu, Cristina Mihaela Olaru, Cristina Orlov-Slavu, Ion Cristian Iaciu, Ana Maria Popa, Radu Constantin Vrabie, Cornelia Nitipir
Publikováno v:
Medicina, Vol 59, Iss 4, p 696 (2023)
Cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors and endocrine therapy are the gold standards for systemic therapy for patients with hormone-positive (HR+)/human epidermal growth factor receptor-2-negative (HER2-) metastatic breast cancer. Followi
Externí odkaz:
https://doaj.org/article/3937aff8b0fd4bc7a9b4c3be4d446f1b
Autor:
Ioana-Miruna Stanciu, Andreea Ioana Parosanu, Cristina Orlov-Slavu, Ion Cristian Iaciu, Ana Maria Popa, Cristina Mihaela Olaru, Cristina Florina Pirlog, Radu Constantin Vrabie, Cornelia Nitipir
Publikováno v:
Diagnostics, Vol 13, Iss 5, p 987 (2023)
The latest and newest discoveries for advanced and metastatic hormone receptor-positive (HR+) and human epidermal growth factor receptor 2-negative (HER2-) breast cancer are the three cyclin-dependent kinases 4 and 6 inhibitors (CDK4/6i) in associati
Externí odkaz:
https://doaj.org/article/6c9da4fa657d4d3eb1982d2cad5f926e
Autor:
Lucian ALECU, Adrian TULIN, Iulian SLAVU, Cristina ORLOV-SLAVU, Bogdan SOCEA, Cornelia NITIPIR
Publikováno v:
Modern Medicine, Vol 27, Iss 4, Pp 261-265 (2020)
Although the standard treatment for ovarian carcinoma with peritoneal metastases is systemic chemotherapy alone or systemic chemotherapy with debulking surgery, a new technique gains more ground: a combination of hipertermic intraperitoneal chemother
Externí odkaz:
https://doaj.org/article/3c57ae64933f42ff802d8c50ecdeea86